Agency Forms Undergoing Paperwork Reduction Act Review, 10700-10701 [2020-03649]
Download as PDF
<![CDATA[
10700
Federal Register / Vol. 85, No. 37 / Tuesday, February 25, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–19BOI]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled the National
Diabetes Prevention Program (DPP)
Introductory Session Project to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on September 4th, 2019 to obtain
comments from the public and affected
agencies. CDC received three comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
National Diabetes Prevention Program
(DPP) Introductory Session Project—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC’s) National Diabetes
Prevention Program lifestyle change
program (National DPP LCP) focused on
helping participants adopt healthier
behaviors (e.g., improving diet,
increasing physical activity, reducing
stress) to prevent or delay the
development of type 2 diabetes. This
proposed project’s primary purposes are
to (1) increase knowledge of recruitment
strategies, specifically introductory
sessions, used by CDC-recognized
organizations to increase enrollment in
the National DPP LCP (Phase 1), and (2)
evaluate the effectiveness of
introductory sessions, specifically a
CDC-developed behaviorally-informed
introductory session known as the Be
Your Best (BYB) Discovery Session, on
enrollment compared with other types
of introductory sessions that
organizations currently use (Phase 2).
CDC is requesting OMB approval to
collect information needed for this
evaluation. For Phase 1 of this project,
the Introductory Session Landscape
Assessment, CDC is seeking approval to
disseminate a brief Landscape
Assessment (survey) to all National DPP
CDC-recognized organizations
(approximately 1,700) and their affiliate
class locations (up to 540). The survey
will initially be disseminated
electronically (web-based survey), and
then a hard copy will be mailed to nonrespondents. The overall evaluation
objectives of the Introductory Session
Landscape Assessment are to increase
knowledge of recruitment strategies
(specifically introductory sessions) used
by CDC-recognized organizations to
increase enrollment in LCPs;
understand how CDC-recognized
organizations are using introductory
sessions, including session content and
delivery; and inform the subsequent
Phase 2 Introductory Session Evaluation
that will evaluate the BYB Discovery
Session compared with other types of
introductory sessions.
For the Phase 2 Introductory Session
Evaluation, CDC is seeking approval to
disseminate the following data
collection tools: (1) Pre-Session Survey
(to be completed by up to 2,640
introductory session attendees), (2) PostSession Survey (to be completed by up
to 2,640 introductory session attendees),
(3) Registration and Attendance
Tracking Form (to be completed by up
to 132 LCP staff), and (4) Discovery
Session Implementation Fidelity
Checklist (to be completed by up to 66
LCP staff). The Pre-Session and PostSession Surveys will be distributed as
hard copies to introductory session
attendees. The BYB Discovery Session
Implementation Fidelity Checklist and
the Registration and Attendance
Tracking Form will be designed in
Microsoft Excel and distributed to
participating LCP staff using secure FTP
upload for LCP personnel to complete
electronically.
Information collected will be
analyzed to evaluate the effectiveness of
the BYB Discovery Session intervention
in increasing enrollment in the National
DPP LCP compared with already
occurring introductory sessions (i.e.,
standard care), with a secondary aim of
better understanding how it is
implemented and the context of its
implementation. This data collection
important because if the BYB Discovery
Session is determined to be an effective
recruitment strategy compared with
other existing introductory sessions, it
should be promoted to maximize the
National DPP’s potential to reduce type
2 diabetes incidence.
jbell on DSKJLSW7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
LCP Staff .........................................................
Introductory Session Attendees (Individuals)
Introductory Session Attendees (Individuals)
Landscape Assessment .................................
Pre-Session Survey .......................................
Post-Session Survey ......................................
VerDate Sep<11>2014
20:34 Feb 24, 2020
Jkt 250001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\25FEN1.SGM
2,240
2,640
2,640
25FEN1
Number of
responses per
respondent
1
1
1
Average
burden per
response
(in hours)
15/60
10/60
10/60
10701
Federal Register / Vol. 85, No. 37 / Tuesday, February 25, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
LCP Staff .........................................................
LCP Staff .........................................................
Registration and Attendance Tracking Form
BYB Discovery Session Implementation Fidelity Checklist.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–03649 Filed 2–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10593, CMS–
2744, and CMS–10652]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
April 27, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
20:34 Feb 24, 2020
Jkt 250001
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number _________, Room C4–
26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10593 Establishment of an
Exchange by a State and Qualified
Health Plans
CMS–2744 End Stage Renal Disease
Annual Facility Survey Form
CMS–10652 Virtual Groups for MeritBased Incentive Payment System
(MIPS)
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
132
66
1
1
Average
burden per
response
(in hours)
15/60
90/60
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved information
collection; Title of Information
Collection: Establishment of an
Exchange by a State and Qualified
Health Plans; Use: The Patient
Protection and Affordable Care Act,
Public Law 111–148, enacted on March
23, 2010, and the Health Care and
Education Reconciliation Act, Public
Law 111–152, enacted on March 30,
2010 (collectively, ‘‘Affordable Care
Act’’), expand access to health
insurance for individuals and
employees of small businesses through
the establishment of new Affordable
Insurance Exchanges (Exchanges),
including the Small Business Health
Options Program (SHOP).
As directed by the rule Establishment
of Exchanges and Qualified Health
Plans; Exchange Standards for
Employers (77 FR 18310) (Exchange
rule), each Exchange will assume
responsibilities related to the
certification and offering of Qualified
Health Plans (QHPs). To offer insurance
through an Exchange, a health insurance
issuer must have its health plans
certified as QHPs by the Exchange. A
QHP must meet certain minimum
certification standards, such as network
adequacy, inclusion of Essential
Community Providers (ECPs), and non-
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 85, Number 37 (Tuesday, February 25, 2020)]
[Notices]
[Pages 10700-10701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03649]
[[Page 10700]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-19BOI]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled the National Diabetes Prevention Program
(DPP) Introductory Session Project to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on September 4th, 2019 to obtain comments from
the public and affected agencies. CDC received three comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
National Diabetes Prevention Program (DPP) Introductory Session
Project--New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC's) National
Diabetes Prevention Program lifestyle change program (National DPP LCP)
focused on helping participants adopt healthier behaviors (e.g.,
improving diet, increasing physical activity, reducing stress) to
prevent or delay the development of type 2 diabetes. This proposed
project's primary purposes are to (1) increase knowledge of recruitment
strategies, specifically introductory sessions, used by CDC-recognized
organizations to increase enrollment in the National DPP LCP (Phase 1),
and (2) evaluate the effectiveness of introductory sessions,
specifically a CDC-developed behaviorally-informed introductory session
known as the Be Your Best (BYB) Discovery Session, on enrollment
compared with other types of introductory sessions that organizations
currently use (Phase 2).
CDC is requesting OMB approval to collect information needed for
this evaluation. For Phase 1 of this project, the Introductory Session
Landscape Assessment, CDC is seeking approval to disseminate a brief
Landscape Assessment (survey) to all National DPP CDC-recognized
organizations (approximately 1,700) and their affiliate class locations
(up to 540). The survey will initially be disseminated electronically
(web-based survey), and then a hard copy will be mailed to non-
respondents. The overall evaluation objectives of the Introductory
Session Landscape Assessment are to increase knowledge of recruitment
strategies (specifically introductory sessions) used by CDC-recognized
organizations to increase enrollment in LCPs; understand how CDC-
recognized organizations are using introductory sessions, including
session content and delivery; and inform the subsequent Phase 2
Introductory Session Evaluation that will evaluate the BYB Discovery
Session compared with other types of introductory sessions.
For the Phase 2 Introductory Session Evaluation, CDC is seeking
approval to disseminate the following data collection tools: (1) Pre-
Session Survey (to be completed by up to 2,640 introductory session
attendees), (2) Post-Session Survey (to be completed by up to 2,640
introductory session attendees), (3) Registration and Attendance
Tracking Form (to be completed by up to 132 LCP staff), and (4)
Discovery Session Implementation Fidelity Checklist (to be completed by
up to 66 LCP staff). The Pre-Session and Post-Session Surveys will be
distributed as hard copies to introductory session attendees. The BYB
Discovery Session Implementation Fidelity Checklist and the
Registration and Attendance Tracking Form will be designed in Microsoft
Excel and distributed to participating LCP staff using secure FTP
upload for LCP personnel to complete electronically.
Information collected will be analyzed to evaluate the
effectiveness of the BYB Discovery Session intervention in increasing
enrollment in the National DPP LCP compared with already occurring
introductory sessions (i.e., standard care), with a secondary aim of
better understanding how it is implemented and the context of its
implementation. This data collection important because if the BYB
Discovery Session is determined to be an effective recruitment strategy
compared with other existing introductory sessions, it should be
promoted to maximize the National DPP's potential to reduce type 2
diabetes incidence.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
LCP Staff............................. Landscape Assessment.... 2,240 1 15/60
Introductory Session Attendees Pre-Session Survey...... 2,640 1 10/60
(Individuals).
Introductory Session Attendees Post-Session Survey..... 2,640 1 10/60
(Individuals).
[[Page 10701]]
LCP Staff............................. Registration and 132 1 15/60
Attendance Tracking
Form.
LCP Staff............................. BYB Discovery Session 66 1 90/60
Implementation Fidelity
Checklist.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-03649 Filed 2-24-20; 8:45 am]
BILLING CODE 4163-18-P
